Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Harrow, Inc. - Common Stock (NQ:HROW)

50.82 +0.95 (+1.90%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Harrow Completes Transfer of the TRIESENCE® New Drug Application
From Harrow, Inc.
Via Business Wire
News headline image
Harrow to Present at Two Investor Conferences in November
From Harrow, Inc.
Via Business Wire
News headline image
Harrow Announces Third Quarter 2023 Financial Results
From Harrow, Inc.
Via Business Wire
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/30
Via Investor Brand Network
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/9
Via Investor Brand Network
News headline image
Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023
From Harrow, Inc.
Via Business Wire
News headline image
Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
From Harrow, Inc.
Via Business Wire
News headline image
Harrow Health, Inc. Changes Corporate Name to Harrow, Inc.
From Harrow Health, Inc.
Via Business Wire
News headline image
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation
From Melt Pharmaceuticals, Inc.
Via Business Wire
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/1
Via Investor Brand Network
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 4/21
Via Investor Brand Network
News headline image
Harrow Announces Second Quarter 2023 Financial Results
From Harrow Health, Inc.
Via Business Wire
News headline image
Harrow Launches VIGAMOX® in the U.S.
From Harrow Health, Inc.
Via Business Wire
News headline image
Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023
From Harrow Health, Inc.
Via Business Wire
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 4/4
Via Investor Brand Network
Harrow Health Inc. (NASDAQ: HROW) Climbs to New 52-Week High
Via Investor Brand Network
News headline image
Harrow Prices $60 Million Public Offering of Common Stock
From Harrow Health, Inc.
Via Business Wire
News headline image
Harrow Acquires Santen’s Branded Ophthalmic Portfolio
From Harrow Health, Inc.
Via Business Wire
News headline image
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
From Harrow Health, Inc.
Via Business Wire
News headline image
Harrow Announces Proposed Public Offering of Common Stock
From Harrow Health, Inc.
Via Business Wire
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 3/22
Via Investor Brand Network
News headline image
Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq
From Harrow Health, Inc.
Via Business Wire
News headline image
Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023
From Harrow
Via Business Wire
News headline image
NASDAQ:HROW Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties at Harrow Health, Inc ↗
San Diego, CA -- (SBWIRE) -- 05/16/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Harrow Health, Inc. 
Via SBWire
News headline image
Harrow Announces First Quarter 2023 Financial Results
From Harrow Health, Inc.
Via Business Wire
News headline image
Harrow to Launch FDA-Approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
From Harrow
Via Business Wire
News headline image
Harrow Launches ILEVRO®, NEVANAC®, and MAXIDEX® in the U.S.
From Harrow
Via Business Wire
News headline image
Harrow to Announce First Quarter 2023 Financial Results on May 11, 2023
From Harrow
Via Business Wire
News headline image
Harrow Announces New $100 Million Secured Credit Facility with Oaktree
From Harrow
Via Business Wire
News headline image
Harrow Announces Fourth Quarter and Year-End 2022 Financial Results
From Harrow
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.